CareDx, Inc (FRA:1K9)
Germany · Delayed Price · Currency is EUR 15.11
-0.13 (-0.85%)
Last updated: Dec 1, 2025, 8:11 AM CET
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
€471,595
Profits / Employee
€92,806
Market Cap
760.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 650 | 7 | 1.09% |
| Dec 31, 2023 | 643 | -95 | -12.87% |
| Dec 31, 2022 | 738 | 93 | 14.42% |
| Dec 31, 2021 | 645 | 170 | 35.79% |
| Dec 31, 2020 | 475 | 89 | 23.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
CareDx News
- 7 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Business Wire
- 7 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Wallstreet:Online
- 21 days ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 24 days ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Business Wire
- 25 days ago - CDNA: BTIG Raises Price Target to $25, Maintains Buy Rating | CDNA Stock News - GuruFocus
- 27 days ago - After-Hours Gainers: VCYT, RIGL, NPCE, CDNA, And FBLG Post Notable Moves Following Q3 Results - Nasdaq
- 27 days ago - CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance - GuruFocus